SCHEMBL5069097

SCHEMBL5069097

CC1=C(C(F)CC2(CNC(=O)c3cc(F)cc(Cl)c3)CCNCC2)C(C)(C)CCC1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CACNA1H O95180 7/20 0.36
GPR139 Q6DWJ6 1/20 0.35
KCNH2 Q12809 4/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
TAS1R2 Q8TE23 1/20 0.34
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
CACNA1I Q9P0X4 2/20 0.32
CACNA1G O43497 1/20 0.32
P2RX7 Q99572 1/20 0.32
CYP2D6 P10635 1/20 0.32
IDO1 P14902 1/20 0.31
SMYD3 Q9H7B4 1/20 0.31
TP53 P04637 1/20 0.31
SCN5A Q14524 1/20 0.31
METAP2 P50579 1/20 0.30
WDR5 P61964 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5069616 0.95 KCNH2 (0.38) CACNA1HKCNH2CHRM1CHRM3CACNA1I
SCHEMBL3046035 0.69 KCNH2 (0.38) CACNA1HGPR139KCNH2TAS1R3TAS1R1
SCHEMBL2882350 0.69 KCNH2 (0.52) CACNA1HKCNH2TAS1R3TAS1R1TAS1R2
SCHEMBL2881618 0.68 KCNH2 (0.56) CACNA1HKCNH2TAS1R3TAS1R1TAS1R2
SCHEMBL5069595 0.67 KCNH2 (0.46) CACNA1HGPR139KCNH2CACNA1IP2RX7
SCHEMBL5067713 0.66 KCNH2 (0.47) CACNA1HKCNH2CHRM1CHRM3CACNA1I
SCHEMBL5069843 0.65 CACNA1H (0.40) CACNA1HKCNH2TAS1R3TAS1R1TAS1R2
SCHEMBL5072494 0.64 KCNH2 (0.41) CACNA1HKCNH2CHRM1CHRM3CACNA1I
SCHEMBL5069850 0.63 KCNH2 (0.40) CACNA1HKCNH2CHRM1CHRM3CACNA1I
SCHEMBL2886622 0.62 KCNH2 (0.58) CACNA1HKCNH2CACNA1IP2RX7CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1901746-A2 4-FLUORO-PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS Merck & Co., Inc. (US) 2008-03-26 EP claimed
WO-2007002884-A2 4-FLUORO-PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS MERCK & CO., INC. (US) 2007-01-04 WO claimed